1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Cannabinoid Receptor
  4. CB2 Isoform
  5. CB2 Antagonist

CB2 Antagonist

CB2 Antagonists (6):

Cat. No. Product Name Effect Purity
  • HY-13505
    AM281
    Antagonist ≥99.0%
    AM281 is a selective CB1 receptor antagonist with an IC50 of 9.91 nM.
  • HY-W011040
    LY320135
    Antagonist
    LY320135 is a potent and selective antagonist of CB1 receptor, with a Ki of 141 nM.
  • HY-133533
    O-2050
    Antagonist
    O-2050 is a high affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM.
  • HY-14788
    Drinabant
    Antagonist
    Drinabant (AVE1625) is an orally active CB1 receptor antagonist.
  • HY-146134
    PGN36
    Antagonist
    PGN36 (Compound 18) is a selective cannabinoid CB2 receptor (CB2R) antagonist with a Ki of 0.09 µM.
  • HY-14791
    Ibipinabant
    Antagonist
    Ibipinabant (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM.